Waystar (NASDAQ:WAY - Get Free Report) had its price objective dropped by JPMorgan Chase & Co. from $40.00 to $38.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price objective would indicate a potential upside of 77.74% from the stock's current price.
Other research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft lowered their price objective on Waystar from $42.00 to $37.00 and set a "buy" rating for the company in a research note on Thursday, March 12th. Morgan Stanley initiated coverage on shares of Waystar in a research report on Monday, March 30th. They set an "equal weight" rating and a $28.00 target price on the stock. Jefferies Financial Group reissued a "buy" rating and set a $41.00 target price on shares of Waystar in a report on Wednesday, February 18th. Raymond James Financial restated a "strong-buy" rating and issued a $32.00 price target on shares of Waystar in a research report on Thursday. Finally, Wall Street Zen cut shares of Waystar from a "buy" rating to a "hold" rating in a research report on Saturday, February 21st. Three analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $36.38.
Check Out Our Latest Stock Analysis on WAY
Waystar Price Performance
Shares of WAY traded down $3.89 during trading hours on Thursday, reaching $21.38. The stock had a trading volume of 8,044,196 shares, compared to its average volume of 2,638,253. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.41 and a current ratio of 1.41. Waystar has a 12 month low of $20.35 and a 12 month high of $42.55. The stock has a market capitalization of $4.10 billion, a PE ratio of 35.05, a PEG ratio of 1.00 and a beta of 0.87. The company's 50-day moving average is $24.65 and its two-hundred day moving average is $29.80.
Waystar (NASDAQ:WAY - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.72 million. Waystar had a return on equity of 6.86% and a net margin of 10.20%.Waystar's quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Research analysts expect that Waystar will post 1.46 EPS for the current year.
Institutional Trading of Waystar
Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in Waystar by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 12,330,872 shares of the company's stock worth $403,836,000 after purchasing an additional 41,062 shares during the last quarter. Advent International L.P. bought a new stake in shares of Waystar in the 4th quarter valued at $362,212,000. William Blair Investment Management LLC increased its position in shares of Waystar by 0.4% during the fourth quarter. William Blair Investment Management LLC now owns 5,282,220 shares of the company's stock worth $172,993,000 after buying an additional 19,033 shares during the period. State Street Corp raised its stake in Waystar by 4.0% during the fourth quarter. State Street Corp now owns 4,134,052 shares of the company's stock worth $135,390,000 after buying an additional 159,183 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in Waystar by 4.5% during the third quarter. Alliancebernstein L.P. now owns 3,415,442 shares of the company's stock worth $129,514,000 after buying an additional 146,510 shares during the last quarter.
Key Stories Impacting Waystar
Here are the key news stories impacting Waystar this week:
Waystar Company Profile
(
Get Free Report)
Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.